Oltipraz
Oltipraz[edit]

Oltipraz is a synthetic dithiolethione compound that has been studied for its potential chemopreventive properties. It is known for its ability to induce phase II detoxification enzymes, which play a crucial role in the metabolism and elimination of carcinogens from the body.
Mechanism of Action[edit]
Oltipraz functions primarily by activating the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway. This activation leads to the upregulation of various antioxidant and detoxification enzymes, such as glutathione S-transferase and NAD(P)H:quinone oxidoreductase 1. These enzymes help in neutralizing reactive oxygen species and in the conjugation and elimination of harmful compounds.
Clinical Applications[edit]
Oltipraz has been investigated for its potential use in the prevention of cancer, particularly in individuals at high risk due to exposure to carcinogens. Studies have focused on its role in reducing the risk of liver cancer in populations exposed to aflatoxins, which are potent carcinogens found in contaminated food supplies.
Pharmacokinetics[edit]
Oltipraz is administered orally and is absorbed through the gastrointestinal tract. It undergoes extensive metabolism in the liver, and its metabolites are excreted primarily through the urine. The pharmacokinetic profile of oltipraz can be influenced by factors such as diet, age, and genetic polymorphisms in metabolic enzymes.
Safety and Side Effects[edit]
While oltipraz has shown promise in preclinical and early clinical studies, its use has been limited by side effects such as gastrointestinal discomfort, fatigue, and skin rashes. Further research is needed to optimize dosing regimens and to identify populations that may benefit most from its use.
Research and Development[edit]
Ongoing research is exploring the potential of oltipraz in combination with other chemopreventive agents and its role in modulating the microbiome to enhance its efficacy. Additionally, studies are investigating its effects on other chronic diseases associated with oxidative stress and inflammation.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian